Abstract
We investigated the effects of a single administration of a cholinesterase inhibitor, tetrahydroaminoacridine (THA, 25 and 50 mg, orally), and an α2-agonist, clonidine (0.5 and 2 μg/kg, orally), on neuropsychologic performance in two groups of patients with Alzheimer's disease (AD). Clonidine enhanced a spatial working memory and verbal fluency, but had no effect on spatial span or word priming. THA enhanced word priming, but had no effect on other performance measures. Our data suggests that degeneration of the LC noradrenergic system and the cholinergic cells of the basal forebrain have different functional consequences during the progression of AD. Finally, a combined treatment with noradrenergic and cholinergic drugs might produce a qualitatively broader effect on cognitive functions than either of the treatments alone, and more effectively attenuate clinical dementia.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Riekkinen P . (1991a): Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease. Neurosci Lett 127: 113–116
Alhainen K, Riekkinen P Sr, Helkala E-L, Partanen J, Laulumaa V, Reinikainen K, Soininen H, Airaksinen M . (1991b): The effect of THA on cognitive functions and spectral power EEG in Alzheimer's disease: preliminary results of an open study. In Iqbal K, McLachlan D, Winblad B, Wisniewski HM (eds), Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. Chichester, John Wiley & Sons, pp 611–619
Arnsten AF, Cai JX . (1993): Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: Indirect effects of yohimbine versus direct effects of clonidine. Neurobiol Aging 14: 597–603
Arnsten AF, Steere JC, Hunt RD . (1996): The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53: 448–455
Baddeley A . (1996): The fractionation of working memory. Proc Natl Acad Sci 93: 13468–13472
Baddeley AD, Della Salla S, Spinnler H . (1991): The two-component hypothesis of memory deficit in Alzheimer's disease. J Clin Exp Neuropsychol 13: 372–380
Becker JT . (1988): Working memory and secondary memory deficits in Alzheimer's disease. J Clin Exp Neuropsychol 10: 739–753
Borkowski JG, Benton AL, Spreen O . (1967): Word fluency and brain damage. Neuropsychologia 5: 135–140
Bowen DM, Smith CB, White P, Davison AN . (1976): Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459–496
Braak H, Braak E . (1996): Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand 165(Suppl):3–12
Bunsey M, Eichenbaum H . (1996): Conservation of hippocampal memory function in rats and humans. Nature 379: 255–257
Coull JT . (1994): Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs and Aging 5: 116–126
Coull JT, Middleton HC, Robbins TW, Sahakian BJ . (1995): Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology 120: 311–321
Drachman DA, Noffsinger D, Sahakian BJ, Kurdziel S, Flemming P . (1980): Aging, memory, and the cholinergic system: A study of dichotic listening. Neurobiol Aging 1: 39–43
Dunnett SB, Barry JE, Robbins T . (1991): The basal forebrain-cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14: 494–501
Goodwin GM, Conway SC, Peyro Saint Paul H, Glabus M, O'Carroll RE, Ebmesier KP . (1997): Executive function and uptake of 99mTc-exametazine shown by single photon emission tomography after oral idazoxan in probable Alzheimer-type dementia. Psychopharmacology 131: 371–378
Heindel WC, Salmon DP, Shults CW, Walicke PA, Butters N . (1989): Neuropsychological evidence for multiple implicit memory systems: A comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci 9: 582–587
Heindel WC, Salmon DP, Butters N . (1991): The biasing of weight judgments in Alzheimer's and Huntington's disease: A priming or programming phenomenon. J Clin Exp Neuropsychol 13: 189–203
Jelicic M, Bonebakker AE, Bonke B . (1995): Implicit memory performance of patients with Alzheimer's disease: A brief review. Int Psychogeriatr 7: 385–392
Kopelman MD, Corn TH . (1988): Cholinergic “blockade” as a model for cholinergic depletion. Brain 111: 1079–1110
Leonard BW, Amaral DG, Squire LR, Zola-Morgan S . (1995): Transient memory impairment in monkeys with bilateral lesions of the entorhinal cortex. J Neurosci 15: 5637–5659
Mair RG, McEntee WJ . (1986): Cognitive enhancement in Korsakoff's psychosis by clonidine: A comparison with l-dopa and ephedrine. Psychopharmacology 88: 444–457
Millner B . (1964): Some effects of frontal lobectomy in man. In Warren JM, Akert K (eds), The Frontal Granular Cortex and Behavior. New York, McGraw-Hill, pp 313–331
Moffoot A, O'Carroll RE, Murray C, Dougall N, Ebmeier K, Goodwin GM . (1994): Clonidine infusion increases uptake of 99m-Tc-exametazine in anterior cingulate cortex psychosis in Korsakoff psychosis. Psychological Medicine 24: 53–61
Mohr E, Schlegel J, Fabbrini G, Williams J, Mouradian MM, Mann UM, Claus JJ, Fedio P, Chase TN . (1989): Clonidine treatment of Alzheimer's disease. Arch Neurol 46: 376–378
Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW . (1990): Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 29: 993–1006
Phelps EA, Hyder F, Blamire AM, Shulma RG . (1997): FMRI of the prefrontal cortex during overt verbal fluency. NeuroReport 8: 561–565
Reinikainen KJ, Riekkinen PJ, Paljärvi L, Soininen H, Helkala E-L, Jolkkonen J, Laakso M . (1988): Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data. Neurochem Res 13: 135–146
Riekkinen M, Soininen H, Kuikka J, Laakso M, Helkala E-L, Partanen J, Riekkinen P Jr . (1998): Tetrahydroaminoacridine improves the recency effect in Alzheimer disease. Neuroscience 83: 471–479
Riekkinen P Jr, Riekkinen M, Soininen H, Kuikka J, Laakso M, Riekkinen P Sr . (1997a): Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease. NeuroReport 8: 1845–1849
Riekkinen P Jr, Soininen H, Partanen J, Pääkkönen A, Helisalmi S, Riekkinen P Sr . (1997b): The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients. Psychopharmacology 129: 285–288
Robbins TW, Elliott R, Sahakian B . (1996): Neuropsychology—dementia and affective disorders. Br Med Bull 52: 627–643
Rueckert L, Appollonio I, Grafman J, Jezzard P, Johnson R Jr, Le Bihan D, Turner R . (1994): Magnetic resonance imaging functional activation of left frontal cortex during covert word production. J Neuroimaging 4: 67–70
Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R . (1993): Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: Assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110: 395–401
Salmon DP, Butters N . (1995): Neurobiology of skill and habit learning. Curr Opin Neurobiol 5: 184–190
Schwartz BL, Hashtroudi S, Herting RL, Schwartz P, Deutsch SI . (1996): d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology 46: 420–424
Shimamura AP, Salmon DP, Squire LR, Butters N . (1987): Memory dysfunction and word priming in dementia and amnesia. Behav Neurosci 101: 347–351
Squire LR . (1987): Memory and Brain. New York, Oxford.
Whitehouse P, Price DL, Struble RG, Clark AW, Coyle JT, DeLong RM . (1982): Alzheimer's disease and senile dementia: Loss of neuron in the basal forebrain. Science 215: 1237–1239
Wilcock GK, Esiri MM . (1982): Plaques, tangles and dementia: A quantitative study. J Neurol Sci 56: 343–356
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riekkinen, P., Riekkinen, M. THA Improves Word Priming and Clonidine Enhances Fluency and Working Memory in Alzheimer's Disease. Neuropsychopharmacol 20, 357–364 (1999). https://doi.org/10.1016/S0893-133X(98)00093-1
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(98)00093-1
Keywords
This article is cited by
-
Tauopathy in transgenic (SHR72) rats impairs function of central noradrenergic system and promotes neuroinflammation
Journal of Neuroinflammation (2016)
-
The Effects of Clonidine on Discrete-Trial Delayed Spatial Alternation in Two Rat Models of Memory Loss
Neuropsychopharmacology (2008)
